nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—acquired immunodeficiency syndrome	0.521	1	CbGaD
Gadobenate Dimeglumine—ALB—Saquinavir—acquired immunodeficiency syndrome	0.128	0.511	CbGbCtD
Gadobenate Dimeglumine—ALB—Zidovudine—acquired immunodeficiency syndrome	0.123	0.489	CbGbCtD
Gadobenate Dimeglumine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000545	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000124	0.000544	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.000543	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000542	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000542	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000541	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000541	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.00054	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000123	0.00054	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000123	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000123	0.000538	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000123	0.000538	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000122	0.000537	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000122	0.000536	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000536	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000535	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000535	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000535	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000535	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000533	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000533	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000529	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000121	0.000529	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000529	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000528	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000528	CcSEcCtD
Gadobenate Dimeglumine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000528	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000527	CcSEcCtD
Gadobenate Dimeglumine—Pain—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000524	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000524	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000524	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000523	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000522	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000119	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.00052	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.00052	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000118	0.000519	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000118	0.000519	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000517	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000517	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000517	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000516	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000515	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000515	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000515	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000515	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000117	0.000511	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000511	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.00051	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000509	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000507	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000504	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000115	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000114	0.000502	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000502	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.0005	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.0005	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000114	0.0005	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.0005	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000498	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000498	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000498	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000496	CcSEcCtD
Gadobenate Dimeglumine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000496	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000496	CcSEcCtD
Gadobenate Dimeglumine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000113	0.000495	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000113	0.000495	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000494	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000113	0.000494	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000493	CcSEcCtD
Gadobenate Dimeglumine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000112	0.000492	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000491	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000491	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000491	CcSEcCtD
Gadobenate Dimeglumine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00049	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000489	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000488	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000488	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000484	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00011	0.000484	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00011	0.000482	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.00048	CcSEcCtD
Gadobenate Dimeglumine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000109	0.00048	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000109	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000109	0.000478	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000478	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000109	0.000478	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000478	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000109	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000108	0.000475	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000108	0.000475	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000475	CcSEcCtD
Gadobenate Dimeglumine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000474	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000474	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.000474	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000108	0.000473	CcSEcCtD
Gadobenate Dimeglumine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000107	0.000471	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000107	0.000471	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000471	CcSEcCtD
Gadobenate Dimeglumine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000107	0.000468	CcSEcCtD
Gadobenate Dimeglumine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000468	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000467	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000106	0.000467	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000467	CcSEcCtD
Gadobenate Dimeglumine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000463	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000462	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000461	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.00046	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00046	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000458	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000458	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000456	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000455	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000453	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000451	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000451	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000103	0.000451	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.00045	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000444	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000443	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000443	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000442	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.00044	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.0001	0.00044	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.00044	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.00044	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000439	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.99e-05	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Pain—Ritonavir—acquired immunodeficiency syndrome	9.99e-05	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.99e-05	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.99e-05	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.94e-05	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.9e-05	0.000434	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.89e-05	0.000434	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.78e-05	0.000429	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.73e-05	0.000427	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.71e-05	0.000426	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.7e-05	0.000425	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.64e-05	0.000423	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.63e-05	0.000422	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.62e-05	0.000422	CcSEcCtD
Gadobenate Dimeglumine—Pain—Saquinavir—acquired immunodeficiency syndrome	9.62e-05	0.000422	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.57e-05	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.57e-05	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.56e-05	0.000419	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.56e-05	0.000419	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.54e-05	0.000419	CcSEcCtD
Gadobenate Dimeglumine—Rash—Zidovudine—acquired immunodeficiency syndrome	9.48e-05	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.48e-05	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.47e-05	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	9.45e-05	0.000414	CcSEcCtD
Gadobenate Dimeglumine—Headache—Zidovudine—acquired immunodeficiency syndrome	9.42e-05	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.35e-05	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.31e-05	0.000408	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.29e-05	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.27e-05	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9.27e-05	0.000406	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.25e-05	0.000406	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.25e-05	0.000406	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.24e-05	0.000405	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.24e-05	0.000405	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.2e-05	0.000404	CcSEcCtD
Gadobenate Dimeglumine—Pain—Lamivudine—acquired immunodeficiency syndrome	9.18e-05	0.000403	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Lamivudine—acquired immunodeficiency syndrome	9.18e-05	0.000403	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	9.07e-05	0.000398	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	9.04e-05	0.000396	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.94e-05	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.94e-05	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.93e-05	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.89e-05	0.00039	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.89e-05	0.00039	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.89e-05	0.00039	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.84e-05	0.000388	CcSEcCtD
Gadobenate Dimeglumine—Rash—Indinavir—acquired immunodeficiency syndrome	8.82e-05	0.000387	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.81e-05	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.78e-05	0.000385	CcSEcCtD
Gadobenate Dimeglumine—Headache—Indinavir—acquired immunodeficiency syndrome	8.76e-05	0.000384	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.74e-05	0.000383	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.65e-05	0.000379	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.61e-05	0.000378	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.53e-05	0.000374	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.48e-05	0.000372	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.48e-05	0.000372	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.4e-05	0.000368	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.39e-05	0.000368	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.36e-05	0.000367	CcSEcCtD
Gadobenate Dimeglumine—Rash—Efavirenz—acquired immunodeficiency syndrome	8.33e-05	0.000365	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.32e-05	0.000365	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Indinavir—acquired immunodeficiency syndrome	8.3e-05	0.000364	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.29e-05	0.000364	CcSEcCtD
Gadobenate Dimeglumine—Headache—Efavirenz—acquired immunodeficiency syndrome	8.28e-05	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.27e-05	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8.07e-05	0.000354	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	8.04e-05	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8e-05	0.000351	CcSEcCtD
Gadobenate Dimeglumine—Rash—Delavirdine—acquired immunodeficiency syndrome	7.97e-05	0.00035	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.96e-05	0.000349	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.96e-05	0.000349	CcSEcCtD
Gadobenate Dimeglumine—Headache—Delavirdine—acquired immunodeficiency syndrome	7.92e-05	0.000347	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.91e-05	0.000347	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.85e-05	0.000344	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.73e-05	0.000339	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.7e-05	0.000338	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.7e-05	0.000338	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.59e-05	0.000333	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.51e-05	0.000329	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.44e-05	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.43e-05	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Rash—Ritonavir—acquired immunodeficiency syndrome	7.37e-05	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.36e-05	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.34e-05	0.000322	CcSEcCtD
Gadobenate Dimeglumine—Headache—Ritonavir—acquired immunodeficiency syndrome	7.32e-05	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000314	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.1e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Rash—Saquinavir—acquired immunodeficiency syndrome	7.09e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.09e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Headache—Saquinavir—acquired immunodeficiency syndrome	7.05e-05	0.000309	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.94e-05	0.000305	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.82e-05	0.000299	CcSEcCtD
Gadobenate Dimeglumine—Rash—Lamivudine—acquired immunodeficiency syndrome	6.77e-05	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.76e-05	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Headache—Lamivudine—acquired immunodeficiency syndrome	6.72e-05	0.000295	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.68e-05	0.000293	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.37e-05	0.00028	CcSEcCtD
